National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

SB-AS02B adjuvant
A proprietary oil-in-water emulsion specifically designed for combining protein preparations used in vaccines. SB-AS02B adjuvant contains monophosphoryl lipid A and QS21, a saponin extracted from the South American tree Quillaja saponaria Molina. This agent may be used for formulating cancer-specific vaccine preparations such as those containing MAGE-3 melanoma protein. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:SB AS02B



Previous:sargramostim plasmid DNA melanoma vaccine adjuvant, sargramostim plasmid DNA pancreatic tumor cell vaccine, satraplatin, Satric, SB-743921
Next:SB-AS15 adjuvant, SC-PEG E. coli L-asparaginase, Sclerosol Intrapleural Aerosol, Se-methyl-seleno-L-cysteine, sedoxantrone trihydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov